within Pharmacolibrary.Drugs.ATC.J;

model J06BC03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.0052833333333333335,
    adminDuration  = 600,
    adminMass      = 1.0,
    adminCount     = 1,
    Vd             = 0.00733,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Bezlotoxumab is a human monoclonal antibody that binds to Clostridioides difficile toxin B and is indicated for the prevention of recurrent C. difficile infection in adults at high risk. It is administered as a single intravenous infusion and is currently approved and used in clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in adult patients with C. difficile infection, primarily males and females aged 18–100 years, without significant hepatic or renal impairment.</p><h4>References</h4><ol><li><p>Chahine, EB, et al., &amp; Worley, MV (2018). Bezlotoxumab for the Prevention of . <i>The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists</i> 33(2) 89–97. DOI:<a href=&quot;https://doi.org/10.4140/TCP.n.2018.89&quot;>10.4140/TCP.n.2018.89</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29409575/&quot;>https://pubmed.ncbi.nlm.nih.gov/29409575</a></p></li><li><p>Reichert, JM (2015). Antibodies to watch in 2015. <i>mAbs</i> 7(1) 1–8. DOI:<a href=&quot;https://doi.org/10.4161/19420862.2015.988944&quot;>10.4161/19420862.2015.988944</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/25484055/&quot;>https://pubmed.ncbi.nlm.nih.gov/25484055</a></p></li><li><p>Kufel, WD, et al., &amp; Daniels, LM (2017). Bezlotoxumab: A Novel Agent for the Prevention of Recurrent Clostridium difficile Infection. <i>Pharmacotherapy</i> 37(10) 1298–1308. DOI:<a href=&quot;https://doi.org/10.1002/phar.1990&quot;>10.1002/phar.1990</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28730660/&quot;>https://pubmed.ncbi.nlm.nih.gov/28730660</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J06BC03;
